UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008387
Receipt number R000009862
Scientific Title Research on the comparison of effect between hormone replacement therapy and keishibukuryogan for patients with climacteric syndrome and relation with the estrogen receptor in the effect
Date of disclosure of the study information 2012/07/09
Last modified on 2012/07/09 16:37:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the comparison of effect between hormone replacement therapy and keishibukuryogan for patients with climacteric syndrome and relation with the estrogen receptor in the effect

Acronym

The effects of hormone replacement therapy and Keishibukuryogan for climacteric syndrome according to
relation to estrogen receptor

Scientific Title

Research on the comparison of effect between hormone replacement therapy and keishibukuryogan for patients with climacteric syndrome and relation with the estrogen receptor in the effect

Scientific Title:Acronym

The effects of hormone replacement therapy and Keishibukuryogan for climacteric syndrome according to
relation to estrogen receptor

Region

Japan


Condition

Condition

climacteric syndrome

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The purpose is establishing the evidence of Kampo medicine treatment in climacteric syndrome by gene polymorphism analysis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement of Kupperman menopausal index

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Keishibukuryogan

Interventions/Control_2

Hormone replacement therapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Female

Key inclusion criteria

1) Positive in Kupperman index
2) Menses was delayed more than one month within the past year, or shorter than 25 days.
3) Hormone value: FSH is equal or more than 20 mIU / ml or anti-mullerian hormone is abnormal value.

Key exclusion criteria

1. Patients in the history of surgery of the ovaries or uterus
2. Patients with hypothyroidism and hyperthyroidism
3. Patients taking drugs of vasodilator
4. Patients with prohibition of estrogen (estrogen-dependent tumor, breast cancer, pregnant woman, serious liver damage, suspicious thrombosis and genital bleeding)

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takao Namiki

Organization

Graduate School of Medicine, Chiba University

Division name

Dept. of Japanese-Oriental(Kampo) Medcine,

Zip code


Address

1-8-1 Inohana Chuo-ku Chiba

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Graduate School of Medicine, Chiba University

Division name

Dept. of Japanese-Oriental(Kampo) Medcine,

Zip code


Address


TEL


Homepage URL


Email

tnamiki@faculty.chiba-u.jp


Sponsor or person

Institute

Takao Namiki

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

UMIN000000186

Org. issuing International ID_1

UMIN

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 09 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 02 Month 11 Day

Date of IRB


Anticipated trial start date

2009 Year 03 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 07 Month 09 Day

Last modified on

2012 Year 07 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009862


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name